nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP11B1—Cimetidine—obesity	0.264	0.711	CbGbCtD
Metoclopramide—DRD2—obesity	0.241	1	CbGaD
Metoclopramide—CYP2D6—Phentermine—obesity	0.0328	0.0884	CbGbCtD
Metoclopramide—CYP2D6—Bupropion—obesity	0.0279	0.0751	CbGbCtD
Metoclopramide—CYP2D6—Methamphetamine—obesity	0.0262	0.0706	CbGbCtD
Metoclopramide—CYP2D6—Cimetidine—obesity	0.0205	0.0551	CbGbCtD
Metoclopramide—HTR3A—area postrema—obesity	0.0197	0.28	CbGeAlD
Metoclopramide—CYP17A1—ovarian follicle—obesity	0.0113	0.161	CbGeAlD
Metoclopramide—HTR3A—vagus nerve—obesity	0.00655	0.0932	CbGeAlD
Metoclopramide—HTR4—adrenal cortex—obesity	0.00364	0.0517	CbGeAlD
Metoclopramide—HTR4—pituitary gland—obesity	0.00294	0.0418	CbGeAlD
Metoclopramide—HTR4—adrenal gland—obesity	0.00263	0.0373	CbGeAlD
Metoclopramide—CYP11B2—adrenal cortex—obesity	0.00205	0.0291	CbGeAlD
Metoclopramide—CYP11B1—adrenal cortex—obesity	0.00205	0.0291	CbGeAlD
Metoclopramide—CYP11B2—cardiovascular system—obesity	0.00187	0.0266	CbGeAlD
Metoclopramide—CYP11B2—adrenal gland—obesity	0.00148	0.021	CbGeAlD
Metoclopramide—CYP11B1—adrenal gland—obesity	0.00148	0.021	CbGeAlD
Metoclopramide—CYP11B2—endocrine gland—obesity	0.00128	0.0182	CbGeAlD
Metoclopramide—CYP11B1—endocrine gland—obesity	0.00128	0.0182	CbGeAlD
Metoclopramide—CYP17A1—adrenal cortex—obesity	0.00125	0.0178	CbGeAlD
Metoclopramide—HTR3A—islet of Langerhans—obesity	0.00124	0.0176	CbGeAlD
Metoclopramide—DRD2—hindbrain—obesity	0.00117	0.0167	CbGeAlD
Metoclopramide—HTR3A—respiratory system—obesity	0.00117	0.0166	CbGeAlD
Metoclopramide—CYP17A1—adrenal gland—obesity	0.000904	0.0129	CbGeAlD
Metoclopramide—CYP17A1—endocrine gland—obesity	0.000784	0.0111	CbGeAlD
Metoclopramide—Sunitinib—STK11—obesity	0.000755	0.148	CrCbGaD
Metoclopramide—HTR3A—digestive system—obesity	0.000744	0.0106	CbGeAlD
Metoclopramide—DRD2—respiratory system—obesity	0.000716	0.0102	CbGeAlD
Metoclopramide—CYP17A1—liver—obesity	0.000706	0.01	CbGeAlD
Metoclopramide—CYP2D6—hindbrain—obesity	0.000704	0.01	CbGeAlD
Metoclopramide—CHRM1—cardiovascular system—obesity	0.000681	0.00968	CbGeAlD
Metoclopramide—Bromopride—DRD2—obesity	0.000626	0.123	CrCbGaD
Metoclopramide—Agranulocytosis—Diethylpropion—obesity	0.000604	0.00375	CcSEcCtD
Metoclopramide—Insomnia—Methamphetamine—obesity	0.000598	0.00371	CcSEcCtD
Metoclopramide—Delirium—Bupropion—obesity	0.000597	0.0037	CcSEcCtD
Metoclopramide—Nervousness—Phenylpropanolamine—obesity	0.000591	0.00366	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Sibutramine—obesity	0.000589	0.00365	CcSEcCtD
Metoclopramide—Amenorrhoea—Bupropion—obesity	0.000584	0.00362	CcSEcCtD
Metoclopramide—Sexual dysfunction—Topiramate—obesity	0.000583	0.00362	CcSEcCtD
Metoclopramide—Insomnia—Benzphetamine—obesity	0.000576	0.00357	CcSEcCtD
Metoclopramide—Agranulocytosis—Cimetidine—obesity	0.000575	0.00357	CcSEcCtD
Metoclopramide—Tremor—Phenylpropanolamine—obesity	0.00057	0.00353	CcSEcCtD
Metoclopramide—Urinary incontinence—Sibutramine—obesity	0.000568	0.00352	CcSEcCtD
Metoclopramide—Tachycardia—Phendimetrazine—obesity	0.000567	0.00352	CcSEcCtD
Metoclopramide—Nervousness—Phentermine—obesity	0.000565	0.0035	CcSEcCtD
Metoclopramide—Bradycardia—Cimetidine—obesity	0.000563	0.00349	CcSEcCtD
Metoclopramide—Fluid retention—Sibutramine—obesity	0.000559	0.00347	CcSEcCtD
Metoclopramide—Agitation—Phenylpropanolamine—obesity	0.000559	0.00346	CcSEcCtD
Metoclopramide—Sunitinib—RPS6KB1—obesity	0.000557	0.109	CrCbGaD
Metoclopramide—Completed suicide—Topiramate—obesity	0.000556	0.00345	CcSEcCtD
Metoclopramide—Hallucination—Cimetidine—obesity	0.00055	0.00341	CcSEcCtD
Metoclopramide—Dyskinesia—Bupropion—obesity	0.000546	0.00339	CcSEcCtD
Metoclopramide—Tremor—Phentermine—obesity	0.000545	0.00338	CcSEcCtD
Metoclopramide—Agitation—Phentermine—obesity	0.000535	0.00332	CcSEcCtD
Metoclopramide—Insomnia—Phendimetrazine—obesity	0.000525	0.00326	CcSEcCtD
Metoclopramide—Urticaria—Methamphetamine—obesity	0.000525	0.00326	CcSEcCtD
Metoclopramide—Anxiety—Phenylpropanolamine—obesity	0.000516	0.0032	CcSEcCtD
Metoclopramide—Palpitations—Phentermine—obesity	0.000514	0.00319	CcSEcCtD
Metoclopramide—Urticaria—Benzphetamine—obesity	0.000506	0.00314	CcSEcCtD
Metoclopramide—Hypertension—Phentermine—obesity	0.000502	0.00311	CcSEcCtD
Metoclopramide—Confusional state—Phenylpropanolamine—obesity	0.0005	0.0031	CcSEcCtD
Metoclopramide—Wheezing—Bupropion—obesity	0.000498	0.00309	CcSEcCtD
Metoclopramide—Urinary incontinence—Bupropion—obesity	0.000496	0.00307	CcSEcCtD
Metoclopramide—Nervousness—Diethylpropion—obesity	0.000492	0.00305	CcSEcCtD
Metoclopramide—Hypersensitivity—Methamphetamine—obesity	0.000487	0.00302	CcSEcCtD
Metoclopramide—DRD2—pituitary gland—obesity	0.000486	0.00691	CbGeAlD
Metoclopramide—Tachycardia—Phenylpropanolamine—obesity	0.000484	0.003	CcSEcCtD
Metoclopramide—Oedema—Phentermine—obesity	0.000475	0.00294	CcSEcCtD
Metoclopramide—Tremor—Diethylpropion—obesity	0.000474	0.00294	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Sibutramine—obesity	0.000471	0.00292	CcSEcCtD
Metoclopramide—Hypersensitivity—Benzphetamine—obesity	0.00047	0.00291	CcSEcCtD
Metoclopramide—CHRM1—endocrine gland—obesity	0.000467	0.00664	CbGeAlD
Metoclopramide—Rash maculo-papular—Bupropion—obesity	0.000466	0.00289	CcSEcCtD
Metoclopramide—Suicidal ideation—Topiramate—obesity	0.000466	0.00289	CcSEcCtD
Metoclopramide—Agitation—Diethylpropion—obesity	0.000465	0.00288	CcSEcCtD
Metoclopramide—Hypotension—Phenylpropanolamine—obesity	0.000464	0.00288	CcSEcCtD
Metoclopramide—Tachycardia—Phentermine—obesity	0.000463	0.00287	CcSEcCtD
Metoclopramide—Sunitinib—TYK2—obesity	0.000461	0.0903	CrCbGaD
Metoclopramide—Gynaecomastia—Bupropion—obesity	0.000459	0.00285	CcSEcCtD
Metoclopramide—Leukopenia—Diethylpropion—obesity	0.000453	0.00281	CcSEcCtD
Metoclopramide—Diarrhoea—Methamphetamine—obesity	0.000452	0.0028	CcSEcCtD
Metoclopramide—Atrial fibrillation—Sibutramine—obesity	0.000451	0.0028	CcSEcCtD
Metoclopramide—Mania—Topiramate—obesity	0.00045	0.00279	CcSEcCtD
Metoclopramide—Renal impairment—Sibutramine—obesity	0.000449	0.00278	CcSEcCtD
Metoclopramide—Insomnia—Phenylpropanolamine—obesity	0.000449	0.00278	CcSEcCtD
Metoclopramide—Palpitations—Diethylpropion—obesity	0.000447	0.00277	CcSEcCtD
Metoclopramide—Agitation—Cimetidine—obesity	0.000443	0.00274	CcSEcCtD
Metoclopramide—Dyspnoea—Phenylpropanolamine—obesity	0.000442	0.00274	CcSEcCtD
Metoclopramide—Somnolence—Phenylpropanolamine—obesity	0.000441	0.00274	CcSEcCtD
Metoclopramide—Convulsion—Diethylpropion—obesity	0.000439	0.00272	CcSEcCtD
Metoclopramide—Dizziness—Methamphetamine—obesity	0.000437	0.00271	CcSEcCtD
Metoclopramide—Diarrhoea—Benzphetamine—obesity	0.000436	0.0027	CcSEcCtD
Metoclopramide—Leukopenia—Cimetidine—obesity	0.000431	0.00267	CcSEcCtD
Metoclopramide—Insomnia—Phentermine—obesity	0.000429	0.00266	CcSEcCtD
Metoclopramide—Anxiety—Diethylpropion—obesity	0.000429	0.00266	CcSEcCtD
Metoclopramide—Dizziness—Benzphetamine—obesity	0.000421	0.00261	CcSEcCtD
Metoclopramide—Headache—Methamphetamine—obesity	0.000414	0.00257	CcSEcCtD
Metoclopramide—Fatigue—Phentermine—obesity	0.000409	0.00254	CcSEcCtD
Metoclopramide—Feeling abnormal—Phenylpropanolamine—obesity	0.000409	0.00254	CcSEcCtD
Metoclopramide—Anxiety—Cimetidine—obesity	0.000409	0.00253	CcSEcCtD
Metoclopramide—Cardiac arrest—Sibutramine—obesity	0.000406	0.00252	CcSEcCtD
Metoclopramide—Tachycardia—Diethylpropion—obesity	0.000403	0.0025	CcSEcCtD
Metoclopramide—Headache—Benzphetamine—obesity	0.000399	0.00248	CcSEcCtD
Metoclopramide—Diarrhoea—Phendimetrazine—obesity	0.000397	0.00246	CcSEcCtD
Metoclopramide—Confusional state—Cimetidine—obesity	0.000396	0.00246	CcSEcCtD
Metoclopramide—Visual disturbance—Bupropion—obesity	0.000393	0.00244	CcSEcCtD
Metoclopramide—Dizziness—Phendimetrazine—obesity	0.000384	0.00238	CcSEcCtD
Metoclopramide—Tachycardia—Cimetidine—obesity	0.000384	0.00238	CcSEcCtD
Metoclopramide—Asthma—Orlistat—obesity	0.000382	0.00237	CcSEcCtD
Metoclopramide—Delirium—Topiramate—obesity	0.00038	0.00236	CcSEcCtD
Metoclopramide—Nausea—Benzphetamine—obesity	0.000379	0.00235	CcSEcCtD
Metoclopramide—Urticaria—Phentermine—obesity	0.000377	0.00234	CcSEcCtD
Metoclopramide—DRD2—endocrine gland—obesity	0.000376	0.00535	CbGeAlD
Metoclopramide—Bronchospasm—Orlistat—obesity	0.000375	0.00233	CcSEcCtD
Metoclopramide—Insomnia—Diethylpropion—obesity	0.000374	0.00232	CcSEcCtD
Metoclopramide—Amenorrhoea—Topiramate—obesity	0.000372	0.00231	CcSEcCtD
Metoclopramide—Asthma—Sibutramine—obesity	0.000369	0.00229	CcSEcCtD
Metoclopramide—Dyspnoea—Diethylpropion—obesity	0.000368	0.00228	CcSEcCtD
Metoclopramide—Somnolence—Diethylpropion—obesity	0.000367	0.00228	CcSEcCtD
Metoclopramide—Hypersensitivity—Phenylpropanolamine—obesity	0.000366	0.00227	CcSEcCtD
Metoclopramide—Headache—Phendimetrazine—obesity	0.000364	0.00226	CcSEcCtD
Metoclopramide—Somnolence—Cimetidine—obesity	0.000349	0.00217	CcSEcCtD
Metoclopramide—Dyskinesia—Topiramate—obesity	0.000348	0.00216	CcSEcCtD
Metoclopramide—Nausea—Phendimetrazine—obesity	0.000345	0.00214	CcSEcCtD
Metoclopramide—Pollakiuria—Sibutramine—obesity	0.000341	0.00212	CcSEcCtD
Metoclopramide—Asthenia—Phentermine—obesity	0.000341	0.00211	CcSEcCtD
Metoclopramide—Feeling abnormal—Diethylpropion—obesity	0.00034	0.00211	CcSEcCtD
Metoclopramide—Erectile dysfunction—Sibutramine—obesity	0.00034	0.00211	CcSEcCtD
Metoclopramide—Depression—Orlistat—obesity	0.000339	0.0021	CcSEcCtD
Metoclopramide—Fatigue—Cimetidine—obesity	0.000339	0.0021	CcSEcCtD
Metoclopramide—Atrioventricular block—Topiramate—obesity	0.000337	0.00209	CcSEcCtD
Metoclopramide—Amisulpride—DRD2—obesity	0.000329	0.0644	CrCbGaD
Metoclopramide—Depression—Sibutramine—obesity	0.000328	0.00204	CcSEcCtD
Metoclopramide—Urticaria—Diethylpropion—obesity	0.000328	0.00203	CcSEcCtD
Metoclopramide—Dizziness—Phenylpropanolamine—obesity	0.000328	0.00203	CcSEcCtD
Metoclopramide—Diarrhoea—Phentermine—obesity	0.000325	0.00201	CcSEcCtD
Metoclopramide—Feeling abnormal—Cimetidine—obesity	0.000324	0.00201	CcSEcCtD
Metoclopramide—Asthma—Bupropion—obesity	0.000322	0.002	CcSEcCtD
Metoclopramide—Oxybuprocaine—BCHE—obesity	0.000321	0.0629	CrCbGaD
Metoclopramide—Bronchospasm—Bupropion—obesity	0.000317	0.00196	CcSEcCtD
Metoclopramide—Urinary incontinence—Topiramate—obesity	0.000316	0.00196	CcSEcCtD
Metoclopramide—Dizziness—Phentermine—obesity	0.000314	0.00195	CcSEcCtD
Metoclopramide—Rash—Phenylpropanolamine—obesity	0.000313	0.00194	CcSEcCtD
Metoclopramide—Dermatitis—Phenylpropanolamine—obesity	0.000313	0.00194	CcSEcCtD
Metoclopramide—Body temperature increased—Cimetidine—obesity	0.000311	0.00193	CcSEcCtD
Metoclopramide—Fluid retention—Topiramate—obesity	0.00031	0.00192	CcSEcCtD
Metoclopramide—Bradycardia—Sibutramine—obesity	0.000301	0.00187	CcSEcCtD
Metoclopramide—Rash—Phentermine—obesity	0.000299	0.00186	CcSEcCtD
Metoclopramide—Dermatitis—Phentermine—obesity	0.000299	0.00185	CcSEcCtD
Metoclopramide—Chloroprocaine—BCHE—obesity	0.000299	0.0584	CrCbGaD
Metoclopramide—Headache—Phentermine—obesity	0.000297	0.00184	CcSEcCtD
Metoclopramide—Pollakiuria—Bupropion—obesity	0.000297	0.00184	CcSEcCtD
Metoclopramide—Rash maculo-papular—Topiramate—obesity	0.000297	0.00184	CcSEcCtD
Metoclopramide—Erectile dysfunction—Bupropion—obesity	0.000297	0.00184	CcSEcCtD
Metoclopramide—Nausea—Phenylpropanolamine—obesity	0.000295	0.00183	CcSEcCtD
Metoclopramide—Hypersensitivity—Cimetidine—obesity	0.00029	0.0018	CcSEcCtD
Metoclopramide—Visual impairment—Sibutramine—obesity	0.000285	0.00177	CcSEcCtD
Metoclopramide—Cinchocaine—BCHE—obesity	0.000285	0.0557	CrCbGaD
Metoclopramide—Procaine—BCHE—obesity	0.000285	0.0557	CrCbGaD
Metoclopramide—Diarrhoea—Diethylpropion—obesity	0.000283	0.00175	CcSEcCtD
Metoclopramide—Nausea—Phentermine—obesity	0.000282	0.00175	CcSEcCtD
Metoclopramide—Asthenia—Cimetidine—obesity	0.000282	0.00175	CcSEcCtD
Metoclopramide—Jaundice—Bupropion—obesity	0.00028	0.00174	CcSEcCtD
Metoclopramide—CYP2D6—digestive system—obesity	0.000274	0.00389	CbGeAlD
Metoclopramide—Dizziness—Diethylpropion—obesity	0.000273	0.00169	CcSEcCtD
Metoclopramide—Diarrhoea—Cimetidine—obesity	0.000269	0.00167	CcSEcCtD
Metoclopramide—Rash—Diethylpropion—obesity	0.00026	0.00162	CcSEcCtD
Metoclopramide—Dermatitis—Diethylpropion—obesity	0.00026	0.00161	CcSEcCtD
Metoclopramide—Dizziness—Cimetidine—obesity	0.00026	0.00161	CcSEcCtD
Metoclopramide—Headache—Diethylpropion—obesity	0.000259	0.0016	CcSEcCtD
Metoclopramide—Hallucination—Bupropion—obesity	0.000256	0.00159	CcSEcCtD
Metoclopramide—Muscle spasms—Orlistat—obesity	0.000256	0.00159	CcSEcCtD
Metoclopramide—Amisulpride—HTR2A—obesity	0.000254	0.0498	CrCbGaD
Metoclopramide—Visual disturbance—Topiramate—obesity	0.00025	0.00155	CcSEcCtD
Metoclopramide—Nervousness—Sibutramine—obesity	0.00025	0.00155	CcSEcCtD
Metoclopramide—Visual impairment—Bupropion—obesity	0.000248	0.00154	CcSEcCtD
Metoclopramide—Rash—Cimetidine—obesity	0.000248	0.00154	CcSEcCtD
Metoclopramide—Dermatitis—Cimetidine—obesity	0.000248	0.00154	CcSEcCtD
Metoclopramide—Muscle spasms—Sibutramine—obesity	0.000247	0.00153	CcSEcCtD
Metoclopramide—Headache—Cimetidine—obesity	0.000246	0.00153	CcSEcCtD
Metoclopramide—Nausea—Diethylpropion—obesity	0.000245	0.00152	CcSEcCtD
Metoclopramide—Angioedema—Orlistat—obesity	0.000243	0.00151	CcSEcCtD
Metoclopramide—Tremor—Sibutramine—obesity	0.000241	0.00149	CcSEcCtD
Metoclopramide—Cisapride—HTR2C—obesity	0.000239	0.0468	CrCbGaD
Metoclopramide—Flushing—Bupropion—obesity	0.000239	0.00148	CcSEcCtD
Metoclopramide—Agitation—Sibutramine—obesity	0.000236	0.00147	CcSEcCtD
Metoclopramide—Angioedema—Sibutramine—obesity	0.000235	0.00146	CcSEcCtD
Metoclopramide—Palpitations—Orlistat—obesity	0.000235	0.00146	CcSEcCtD
Metoclopramide—Nausea—Cimetidine—obesity	0.000233	0.00145	CcSEcCtD
Metoclopramide—Convulsion—Orlistat—obesity	0.00023	0.00143	CcSEcCtD
Metoclopramide—Leukopenia—Sibutramine—obesity	0.00023	0.00143	CcSEcCtD
Metoclopramide—Palpitations—Sibutramine—obesity	0.000227	0.00141	CcSEcCtD
Metoclopramide—CYP2D6—endocrine gland—obesity	0.000226	0.00321	CbGeAlD
Metoclopramide—Anxiety—Orlistat—obesity	0.000226	0.0014	CcSEcCtD
Metoclopramide—Convulsion—Sibutramine—obesity	0.000223	0.00138	CcSEcCtD
Metoclopramide—Hypertension—Sibutramine—obesity	0.000222	0.00138	CcSEcCtD
Metoclopramide—Anxiety—Sibutramine—obesity	0.000218	0.00135	CcSEcCtD
Metoclopramide—Nervousness—Bupropion—obesity	0.000218	0.00135	CcSEcCtD
Metoclopramide—Oedema—Orlistat—obesity	0.000217	0.00135	CcSEcCtD
Metoclopramide—Muscle spasms—Bupropion—obesity	0.000216	0.00134	CcSEcCtD
Metoclopramide—Confusional state—Sibutramine—obesity	0.000212	0.00131	CcSEcCtD
Metoclopramide—Tremor—Bupropion—obesity	0.00021	0.0013	CcSEcCtD
Metoclopramide—Oedema—Sibutramine—obesity	0.00021	0.0013	CcSEcCtD
Metoclopramide—Agitation—Bupropion—obesity	0.000206	0.00128	CcSEcCtD
Metoclopramide—Asthma—Topiramate—obesity	0.000205	0.00127	CcSEcCtD
Metoclopramide—Angioedema—Bupropion—obesity	0.000205	0.00127	CcSEcCtD
Metoclopramide—Tachycardia—Sibutramine—obesity	0.000205	0.00127	CcSEcCtD
Metoclopramide—CYP2D6—liver—obesity	0.000204	0.0029	CbGeAlD
Metoclopramide—Leukopenia—Bupropion—obesity	0.000201	0.00125	CcSEcCtD
Metoclopramide—Procainamide—SLC22A1—obesity	0.000199	0.0389	CrCbGaD
Metoclopramide—Palpitations—Bupropion—obesity	0.000198	0.00123	CcSEcCtD
Metoclopramide—Cisapride—DRD2—obesity	0.000197	0.0386	CrCbGaD
Metoclopramide—Insomnia—Orlistat—obesity	0.000196	0.00122	CcSEcCtD
Metoclopramide—Hypotension—Sibutramine—obesity	0.000196	0.00122	CcSEcCtD
Metoclopramide—Convulsion—Bupropion—obesity	0.000194	0.00121	CcSEcCtD
Metoclopramide—Hypertension—Bupropion—obesity	0.000194	0.0012	CcSEcCtD
Metoclopramide—Neutropenia—Topiramate—obesity	0.000192	0.00119	CcSEcCtD
Metoclopramide—Anxiety—Bupropion—obesity	0.00019	0.00118	CcSEcCtD
Metoclopramide—Insomnia—Sibutramine—obesity	0.00019	0.00118	CcSEcCtD
Metoclopramide—Pollakiuria—Topiramate—obesity	0.000189	0.00117	CcSEcCtD
Metoclopramide—Erectile dysfunction—Topiramate—obesity	0.000189	0.00117	CcSEcCtD
Metoclopramide—Dyspnoea—Sibutramine—obesity	0.000187	0.00116	CcSEcCtD
Metoclopramide—Fatigue—Orlistat—obesity	0.000187	0.00116	CcSEcCtD
Metoclopramide—Somnolence—Sibutramine—obesity	0.000187	0.00116	CcSEcCtD
Metoclopramide—Confusional state—Bupropion—obesity	0.000185	0.00114	CcSEcCtD
Metoclopramide—Oedema—Bupropion—obesity	0.000183	0.00114	CcSEcCtD
Metoclopramide—Depression—Topiramate—obesity	0.000182	0.00113	CcSEcCtD
Metoclopramide—Feeling abnormal—Orlistat—obesity	0.000179	0.00111	CcSEcCtD
Metoclopramide—Tachycardia—Bupropion—obesity	0.000179	0.00111	CcSEcCtD
Metoclopramide—Feeling abnormal—Sibutramine—obesity	0.000173	0.00107	CcSEcCtD
Metoclopramide—Urticaria—Orlistat—obesity	0.000172	0.00107	CcSEcCtD
Metoclopramide—Body temperature increased—Orlistat—obesity	0.000172	0.00106	CcSEcCtD
Metoclopramide—Hypotension—Bupropion—obesity	0.000171	0.00106	CcSEcCtD
Metoclopramide—Agranulocytosis—Topiramate—obesity	0.000171	0.00106	CcSEcCtD
Metoclopramide—Bradycardia—Topiramate—obesity	0.000167	0.00104	CcSEcCtD
Metoclopramide—Urticaria—Sibutramine—obesity	0.000167	0.00103	CcSEcCtD
Metoclopramide—Body temperature increased—Sibutramine—obesity	0.000166	0.00103	CcSEcCtD
Metoclopramide—Insomnia—Bupropion—obesity	0.000166	0.00103	CcSEcCtD
Metoclopramide—Hallucination—Topiramate—obesity	0.000163	0.00101	CcSEcCtD
Metoclopramide—Dyspnoea—Bupropion—obesity	0.000163	0.00101	CcSEcCtD
Metoclopramide—Somnolence—Bupropion—obesity	0.000163	0.00101	CcSEcCtD
Metoclopramide—Hypersensitivity—Orlistat—obesity	0.00016	0.000991	CcSEcCtD
Metoclopramide—Visual impairment—Topiramate—obesity	0.000158	0.000981	CcSEcCtD
Metoclopramide—Fatigue—Bupropion—obesity	0.000158	0.000979	CcSEcCtD
Metoclopramide—Asthenia—Orlistat—obesity	0.000156	0.000965	CcSEcCtD
Metoclopramide—Hypersensitivity—Sibutramine—obesity	0.000155	0.000959	CcSEcCtD
Metoclopramide—Flushing—Topiramate—obesity	0.000152	0.000945	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—obesity	0.000152	0.0298	CrCbGaD
Metoclopramide—Feeling abnormal—Bupropion—obesity	0.000151	0.000935	CcSEcCtD
Metoclopramide—Asthenia—Sibutramine—obesity	0.000151	0.000934	CcSEcCtD
Metoclopramide—Diarrhoea—Orlistat—obesity	0.000148	0.000921	CcSEcCtD
Metoclopramide—Procainamide—BCHE—obesity	0.000147	0.0289	CrCbGaD
Metoclopramide—Urticaria—Bupropion—obesity	0.000145	0.000902	CcSEcCtD
Metoclopramide—Body temperature increased—Bupropion—obesity	0.000145	0.000897	CcSEcCtD
Metoclopramide—Diarrhoea—Sibutramine—obesity	0.000144	0.000891	CcSEcCtD
Metoclopramide—Dizziness—Orlistat—obesity	0.000143	0.00089	CcSEcCtD
Metoclopramide—Dizziness—Sibutramine—obesity	0.000139	0.000861	CcSEcCtD
Metoclopramide—Nervousness—Topiramate—obesity	0.000139	0.000861	CcSEcCtD
Metoclopramide—Muscle spasms—Topiramate—obesity	0.000137	0.000852	CcSEcCtD
Metoclopramide—Rash—Orlistat—obesity	0.000137	0.000848	CcSEcCtD
Metoclopramide—Dermatitis—Orlistat—obesity	0.000137	0.000848	CcSEcCtD
Metoclopramide—Headache—Orlistat—obesity	0.000136	0.000843	CcSEcCtD
Metoclopramide—Hypersensitivity—Bupropion—obesity	0.000135	0.000836	CcSEcCtD
Metoclopramide—Tremor—Topiramate—obesity	0.000134	0.00083	CcSEcCtD
Metoclopramide—Rash—Sibutramine—obesity	0.000132	0.000821	CcSEcCtD
Metoclopramide—Dermatitis—Sibutramine—obesity	0.000132	0.00082	CcSEcCtD
Metoclopramide—Headache—Sibutramine—obesity	0.000132	0.000816	CcSEcCtD
Metoclopramide—Asthenia—Bupropion—obesity	0.000131	0.000815	CcSEcCtD
Metoclopramide—Agitation—Topiramate—obesity	0.000131	0.000814	CcSEcCtD
Metoclopramide—Nausea—Orlistat—obesity	0.000129	0.000799	CcSEcCtD
Metoclopramide—Leukopenia—Topiramate—obesity	0.000128	0.000793	CcSEcCtD
Metoclopramide—Palpitations—Topiramate—obesity	0.000126	0.000783	CcSEcCtD
Metoclopramide—Diarrhoea—Bupropion—obesity	0.000125	0.000777	CcSEcCtD
Metoclopramide—Nausea—Sibutramine—obesity	0.000125	0.000773	CcSEcCtD
Metoclopramide—Convulsion—Topiramate—obesity	0.000124	0.000768	CcSEcCtD
Metoclopramide—Hypertension—Topiramate—obesity	0.000123	0.000765	CcSEcCtD
Metoclopramide—Anxiety—Topiramate—obesity	0.000121	0.000752	CcSEcCtD
Metoclopramide—Dizziness—Bupropion—obesity	0.000121	0.000751	CcSEcCtD
Metoclopramide—Confusional state—Topiramate—obesity	0.000118	0.000729	CcSEcCtD
Metoclopramide—Oedema—Topiramate—obesity	0.000117	0.000723	CcSEcCtD
Metoclopramide—Rash—Bupropion—obesity	0.000115	0.000716	CcSEcCtD
Metoclopramide—Dermatitis—Bupropion—obesity	0.000115	0.000715	CcSEcCtD
Metoclopramide—Headache—Bupropion—obesity	0.000115	0.000711	CcSEcCtD
Metoclopramide—Tachycardia—Topiramate—obesity	0.000114	0.000706	CcSEcCtD
Metoclopramide—Hypotension—Topiramate—obesity	0.000109	0.000676	CcSEcCtD
Metoclopramide—Nausea—Bupropion—obesity	0.000109	0.000674	CcSEcCtD
Metoclopramide—Insomnia—Topiramate—obesity	0.000106	0.000654	CcSEcCtD
Metoclopramide—Dyspnoea—Topiramate—obesity	0.000104	0.000645	CcSEcCtD
Metoclopramide—Somnolence—Topiramate—obesity	0.000104	0.000643	CcSEcCtD
Metoclopramide—Fatigue—Topiramate—obesity	0.000101	0.000624	CcSEcCtD
Metoclopramide—Feeling abnormal—Topiramate—obesity	9.61e-05	0.000596	CcSEcCtD
Metoclopramide—Urticaria—Topiramate—obesity	9.27e-05	0.000575	CcSEcCtD
Metoclopramide—Body temperature increased—Topiramate—obesity	9.22e-05	0.000572	CcSEcCtD
Metoclopramide—Hypersensitivity—Topiramate—obesity	8.59e-05	0.000533	CcSEcCtD
Metoclopramide—Asthenia—Topiramate—obesity	8.37e-05	0.000519	CcSEcCtD
Metoclopramide—Diarrhoea—Topiramate—obesity	7.98e-05	0.000495	CcSEcCtD
Metoclopramide—Dizziness—Topiramate—obesity	7.71e-05	0.000478	CcSEcCtD
Metoclopramide—Rash—Topiramate—obesity	7.35e-05	0.000456	CcSEcCtD
Metoclopramide—Dermatitis—Topiramate—obesity	7.35e-05	0.000456	CcSEcCtD
Metoclopramide—Headache—Topiramate—obesity	7.31e-05	0.000453	CcSEcCtD
Metoclopramide—Nausea—Topiramate—obesity	6.93e-05	0.00043	CcSEcCtD
Metoclopramide—CYP2D6—Metabolism—GLP1R—obesity	4.8e-06	3.18e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CB—obesity	4.8e-06	3.18e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CG—obesity	4.79e-06	3.18e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTPN1—obesity	4.77e-06	3.16e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GCG—obesity	4.77e-06	3.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TCF7L2—obesity	4.75e-06	3.15e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PIK3CA—obesity	4.73e-06	3.14e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT2—obesity	4.72e-06	3.13e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DPYD—obesity	4.72e-06	3.13e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD2—obesity	4.71e-06	3.12e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CG—obesity	4.69e-06	3.11e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTPN1—obesity	4.67e-06	3.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GCG—obesity	4.67e-06	3.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CD—obesity	4.64e-06	3.07e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—obesity	4.56e-06	3.02e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRL—obesity	4.55e-06	3.02e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PRKAR2B—obesity	4.54e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CD—obesity	4.54e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DCN—obesity	4.51e-06	2.99e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCD—obesity	4.5e-06	2.99e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STK11—obesity	4.48e-06	2.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—obesity	4.46e-06	2.96e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—obesity	4.46e-06	2.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRL—obesity	4.45e-06	2.95e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLG—obesity	4.43e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—RHOA—obesity	4.43e-06	2.93e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—obesity	4.41e-06	2.92e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—C3—obesity	4.4e-06	2.92e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CPT1A—obesity	4.39e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STK11—obesity	4.39e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT2—obesity	4.38e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3R1—obesity	4.38e-06	2.9e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—obesity	4.37e-06	2.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLG—obesity	4.34e-06	2.88e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—RHOA—obesity	4.33e-06	2.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FOXO3—obesity	4.33e-06	2.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB2—obesity	4.32e-06	2.86e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NAMPT—obesity	4.3e-06	2.85e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT2—obesity	4.29e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3R1—obesity	4.29e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LIPC—obesity	4.28e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCK—obesity	4.28e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOC3—obesity	4.25e-06	2.82e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS1—obesity	4.25e-06	2.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FOXO3—obesity	4.23e-06	2.81e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PIK3CA—obesity	4.23e-06	2.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB2—obesity	4.22e-06	2.8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CD—obesity	4.21e-06	2.79e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS3—obesity	4.2e-06	2.78e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—obesity	4.19e-06	2.78e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IRS2—obesity	4.19e-06	2.78e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGT—obesity	4.18e-06	2.77e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS1—obesity	4.16e-06	2.76e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CETP—obesity	4.13e-06	2.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CD—obesity	4.12e-06	2.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNB3—obesity	4.11e-06	2.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS3—obesity	4.11e-06	2.72e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LEP—obesity	4.1e-06	2.72e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—obesity	4.1e-06	2.72e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SDC1—obesity	4.08e-06	2.7e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CAV1—obesity	4.06e-06	2.69e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TYK2—obesity	4.05e-06	2.69e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOA1—obesity	4.05e-06	2.69e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CB—obesity	4.04e-06	2.68e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF2—obesity	4.04e-06	2.68e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNB3—obesity	4.02e-06	2.67e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RHOA—obesity	4.02e-06	2.66e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKR1C3—obesity	4.01e-06	2.66e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNAS—obesity	4e-06	2.65e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3R1—obesity	3.98e-06	2.64e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TYK2—obesity	3.97e-06	2.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CB—obesity	3.96e-06	2.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SCARB1—obesity	3.95e-06	2.62e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF2—obesity	3.95e-06	2.62e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RHOA—obesity	3.93e-06	2.61e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOB—obesity	3.92e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNAS—obesity	3.92e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—obesity	3.91e-06	2.59e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3R1—obesity	3.89e-06	2.58e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—obesity	3.87e-06	2.56e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—F2—obesity	3.87e-06	2.56e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCB—obesity	3.87e-06	2.56e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SREBF1—obesity	3.84e-06	2.54e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOB—obesity	3.83e-06	2.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL5—obesity	3.83e-06	2.54e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BAD—obesity	3.82e-06	2.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL5—obesity	3.74e-06	2.48e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LPL—obesity	3.74e-06	2.48e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT2—obesity	3.73e-06	2.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FOXO1—obesity	3.71e-06	2.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RPS6KB1—obesity	3.71e-06	2.46e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CG—obesity	3.7e-06	2.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CB—obesity	3.67e-06	2.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LPL—obesity	3.66e-06	2.43e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IRS1—obesity	3.66e-06	2.42e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—FASN—obesity	3.65e-06	2.42e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CA—obesity	3.65e-06	2.42e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BCHE—obesity	3.64e-06	2.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FOXO1—obesity	3.64e-06	2.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RPS6KB1—obesity	3.63e-06	2.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CB—obesity	3.59e-06	2.38e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—obesity	3.52e-06	2.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2E1—obesity	3.51e-06	2.33e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—INS—obesity	3.5e-06	2.32e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NQO1—obesity	3.47e-06	2.3e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—obesity	3.46e-06	2.29e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCD—obesity	3.45e-06	2.29e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—obesity	3.44e-06	2.28e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CA—obesity	3.41e-06	2.26e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1—obesity	3.39e-06	2.25e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT2—obesity	3.38e-06	2.24e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCD—obesity	3.37e-06	2.24e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—obesity	3.37e-06	2.24e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C3—obesity	3.37e-06	2.23e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCG—obesity	3.33e-06	2.2e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC2A4—obesity	3.33e-06	2.2e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—obesity	3.3e-06	2.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C3—obesity	3.3e-06	2.19e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYCS—obesity	3.28e-06	2.18e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CD—obesity	3.25e-06	2.16e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GGT1—obesity	3.22e-06	2.14e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT1—obesity	3.22e-06	2.14e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CA—obesity	3.22e-06	2.14e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SERPINE1—obesity	3.22e-06	2.13e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IRS2—obesity	3.2e-06	2.12e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGT—obesity	3.2e-06	2.12e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NCOA1—obesity	3.17e-06	2.1e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IRS2—obesity	3.14e-06	2.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LEP—obesity	3.14e-06	2.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—obesity	3.14e-06	2.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGT—obesity	3.13e-06	2.08e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TYK2—obesity	3.13e-06	2.07e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—STK11—obesity	3.13e-06	2.07e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP19A1—obesity	3.13e-06	2.07e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CAV1—obesity	3.11e-06	2.06e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RHOA—obesity	3.1e-06	2.06e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOA1—obesity	3.1e-06	2.06e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—obesity	3.07e-06	2.04e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3R1—obesity	3.07e-06	2.04e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LEP—obesity	3.07e-06	2.03e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—obesity	3.07e-06	2.03e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CAV1—obesity	3.04e-06	2.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOA1—obesity	3.03e-06	2.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—obesity	2.99e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—obesity	2.98e-06	1.97e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—F2—obesity	2.96e-06	1.96e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCB—obesity	2.96e-06	1.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—obesity	2.93e-06	1.94e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CA—obesity	2.92e-06	1.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BAD—obesity	2.92e-06	1.94e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—COMT—obesity	2.91e-06	1.93e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—F2—obesity	2.89e-06	1.92e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCB—obesity	2.89e-06	1.92e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GNB3—obesity	2.87e-06	1.9e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARGC1A—obesity	2.87e-06	1.9e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BAD—obesity	2.86e-06	1.9e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—obesity	2.85e-06	1.89e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MTOR—obesity	2.83e-06	1.88e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CB—obesity	2.83e-06	1.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CG—obesity	2.83e-06	1.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IRS1—obesity	2.8e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GNAS—obesity	2.79e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—obesity	2.79e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CG—obesity	2.77e-06	1.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IRS1—obesity	2.74e-06	1.82e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOB—obesity	2.73e-06	1.81e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—obesity	2.69e-06	1.79e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—INS—obesity	2.68e-06	1.78e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—obesity	2.64e-06	1.75e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—obesity	2.64e-06	1.75e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—obesity	2.63e-06	1.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—INS—obesity	2.62e-06	1.74e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LPL—obesity	2.61e-06	1.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1—obesity	2.59e-06	1.72e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—obesity	2.59e-06	1.72e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT2—obesity	2.59e-06	1.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—obesity	2.58e-06	1.71e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX1—obesity	2.55e-06	1.69e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1—obesity	2.54e-06	1.68e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT2—obesity	2.53e-06	1.68e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CD—obesity	2.49e-06	1.65e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CD36—obesity	2.48e-06	1.64e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CA—obesity	2.46e-06	1.63e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—obesity	2.46e-06	1.63e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SERPINE1—obesity	2.46e-06	1.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CD—obesity	2.44e-06	1.61e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CA—obesity	2.41e-06	1.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SERPINE1—obesity	2.41e-06	1.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—obesity	2.4e-06	1.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TYK2—obesity	2.39e-06	1.59e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—obesity	2.39e-06	1.58e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RHOA—obesity	2.37e-06	1.57e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—obesity	2.35e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—obesity	2.35e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3R1—obesity	2.35e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TYK2—obesity	2.34e-06	1.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RHOA—obesity	2.32e-06	1.54e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARA—obesity	2.31e-06	1.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—obesity	2.3e-06	1.52e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3R1—obesity	2.3e-06	1.52e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CA—obesity	2.24e-06	1.48e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AGT—obesity	2.23e-06	1.48e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT3—obesity	2.19e-06	1.45e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CA—obesity	2.19e-06	1.45e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—obesity	2.19e-06	1.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MTOR—obesity	2.17e-06	1.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CB—obesity	2.17e-06	1.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAV1—obesity	2.17e-06	1.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOA1—obesity	2.16e-06	1.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MTOR—obesity	2.12e-06	1.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CB—obesity	2.12e-06	1.41e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MYC—obesity	2.04e-06	1.35e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—obesity	2.03e-06	1.35e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—obesity	2.01e-06	1.33e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—obesity	1.98e-06	1.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CG—obesity	1.97e-06	1.31e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—obesity	1.97e-06	1.31e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—obesity	1.94e-06	1.29e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—obesity	1.91e-06	1.26e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—obesity	1.89e-06	1.25e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—obesity	1.88e-06	1.25e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—INS—obesity	1.87e-06	1.24e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—obesity	1.84e-06	1.22e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—obesity	1.83e-06	1.22e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—obesity	1.83e-06	1.21e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—obesity	1.79e-06	1.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—obesity	1.79e-06	1.19e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CD—obesity	1.74e-06	1.15e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CA—obesity	1.73e-06	1.15e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—obesity	1.71e-06	1.14e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT3—obesity	1.68e-06	1.11e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT3—obesity	1.64e-06	1.09e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3R1—obesity	1.64e-06	1.09e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—obesity	1.64e-06	1.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MYC—obesity	1.56e-06	1.03e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—obesity	1.55e-06	1.03e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—obesity	1.53e-06	1.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MYC—obesity	1.52e-06	1.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—obesity	1.52e-06	1.01e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CB—obesity	1.51e-06	1e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—obesity	1.5e-06	9.94e-06	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—obesity	1.41e-06	9.36e-06	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CA—obesity	1.32e-06	8.76e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CA—obesity	1.29e-06	8.58e-06	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—obesity	1.17e-06	7.76e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—obesity	1.15e-06	7.6e-06	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—obesity	1.08e-06	7.16e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—obesity	1.06e-06	7.01e-06	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CA—obesity	9.22e-07	6.11e-06	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—obesity	7.53e-07	4.99e-06	CbGpPWpGaD
